Filing Flows › Bio Key International (BKYI) › R&D spending
Bio Key International (BKYI) R&D spending by quarter
Bio Key International's R&D spending was $640K in Q2 2026 (second quarter 2026), +4% from Q1 2026. Over the last 7 quarters it ranged from $596K (Q1 2025) to $694K (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $640K | +4% | +0.7% |
| Q1 2026 | $617K | -11% | +4% |
| Q4 2025 | $694K | +2% | +5% |
| Q3 2025 | $684K | +7% | — |
| Q2 2025 | $636K | +7% | — |
| Q1 2025 | $596K | -10% | — |
| Q4 2024 | $660K | — | — |
Q2 2026 at a glance
Bio Key International, Q2 2026: revenue $1.9M (+13% year over year), operating margin -27.6%, net loss $577K, operating cash flow −$846K. The chart follows the revenue to costs, profit and cash.
Questions
What is Bio Key International's R&D spending?
Bio Key International's R&D spending was $640K in Q2 2026 (second quarter 2026), +4% from Q1 2026.
How has Bio Key International's R&D spending changed?
Over the last 7 quarters it ranged from $596K (Q1 2025) to $694K (Q4 2025).